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Background: The first Lippes Loop intrauterine device (IUD) was introduced in 1962. It was a plastic double “S”
loop, a trapezoid shaped IUD that closely fit around the contours of the uterine cavity, reducing the incidence of
expulsion. This IUD was commonly used from the 1960’s to the 1980’s. Some authors state that the IUD can be left
in the uterine cavity for an indefinite amount of time. Prolonged use of this device was common, however, it was
associated with some complications like uterine bleeding during post-menopausal period and inflammatory pelvic
diseases.
Case presentation: The patient was a 74-years-old woman who was admitted to a university hospital due to
urinary incontinence stress. The patient’s history included 2 deliveries and 20 years of menopause. During
ultrasonography a normally sized and shaped uterus was found. The uterine cavity was expanded by 14 mm with
some fluid. A “Lippes” loop was also seen in the uterine cavity. Both ovaries were atrophic without any abnormalities.
The patient had her IUD inserted 50 years ago. Patient underwent TOT (tension obturator tape ) surgery for urinary
incontinence. Evacuation of IUD and uterine curettage was also done.
Conclusions: Fifty years of prolonged usage of LIPPES IUD had no influence on the woman’s health during our case.
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The intrauterine device (IUD) is the most commonly
used contraceptive method in the world [1-3]. It is
effective, long-acting and rapidly reversible. It is one of
the most cost-effective methods as well and can be used
by most women, including those who have to avoid
estrogens [2,3]. The use of the IUD is associated with
some complications, including the risk of uterine perfor-
ation, malposition and expulsion of the device, abnormal
bleeding and infections [3-6]. There have been reported
cases of some women with expired IUD’s [4,6,7].
Case presentation
We present a case of a intrauterine device that was
inserted 50 years ago.
The patient was a 74-years-old woman who was
admitted to a university hospital due to stress urinary
incontinence. The patient’s history included 2 deliveries* Correspondence: rositaan@hotmail.com
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article, unless otherwise stated.and 20 years of menopause. During ultrasonography a
normally sized and shaped uterus was found. The uter-
ine cavity was expanded by 14 mm with some fluid. A
“Lippes” loop was also found in the uterine cavity. Both
ovaries were atrophic without any abnormalities. The
patient had her IUD inserted 50 years ago. There had
been attempts of extracting it after a few years of inser-
tion, but was ultimately not successful and the woman
forgot about it. The patient underwent TOT surgery for
urinary incontinence. Evacuation of the IUD and uterine
curettage was also done (Figures 1 and 2). Histological
exam revealed no abnormalities. Postoperative period
was without complications and two days after surgery
the patient was discharged.
Discussion
Lippes Loop intrauterine device was first introduced in
1962. It was a plastic double “S” loop, a trapezoidal
shaped IUD that closely fit the contours of the uterine
cavity, thereby reducing the incidence of expulsion [1,7].
This IUD was commonly used from the 1960s to the
1980s [1]. Some authors states that this IUD can be leftCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
Figure 1 Patient during TOT operation.
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[7]. Prolonged use of this device was common, however,
it was associated with some complications like uterine
bleeding during post-menopausal period and inflamma-
tory pelvic disease [1,4-7].
There have been reported cases of prolonged usage of
the IUD [1,4,8]. The time period of retained uterine de-
vices varied from 22 to 44 years. Those women, most
commonly, were presented to a specialist complaining of
bleeding during a post-menopausal period [1,4]. The
cause of the bleeding can be deducted to be the device’s
migration into the uterine wall and also a chronic in-
flammatory response of the endometrium [4]. However,
women with IUD presented with bleeding after a meno-
pause should be closely examined, as it can represent a
significant endometrial pathology. Investigation should
include visualization of the endometrial cavity by hyster-
oscopy, as the measurement of the endometrial thick-
ness during an ultrasound exam may be unreliable inFigure 2 Lippes Loop IUD after evacuation.the presence of an IUD [1]. Another reported case of a
32-year-old woman with a long-standing intrauterine de-
vice who developed an abdominal wall actinomycosis
[8]. The diagnosis was established late by histopatho-
logical examinations after an initial surgical procedure
was done, in which the abscess was evacuated and all
the necrotic tissue was excised. Post operatively, the pa-
tient developed two intra-abdominal abscesses which
were treated with surgical drainage. The combination of
long-term high dose antibiotic therapy and surgery led
to a successful management of the condition. Abdominal
wall actinomycosis should be considered for intrauterine
device users who are presented with abdominal ab-
scesses of unknown origin [8].
Perforation of the uterus by an IUD has been reported
on numerous occasions and, depending upon the degree
of penetration through the myometrium, can be partial
or complete [4]. A case was reported of a woman with
Lippes loop who had a perforation of the uterus after
having the device inserted 35 years ago. She presented
an acute abdominal pain and underwent laparotomy and
an postoperative pathological report demonstrated char-
acteristics of actinomycosis associated with perforation
[6]. It is noted that infection is most common during the
first year after insertion of the device but may occur at
any time. This is caused by microorganisms’ migration
from the vagina and cervical canal along the threads of
the uterine device [7]. To address these concerns, the
authors (Farley TM, Rosenberg MJ et al.) have reviewed
the World Health Organisation’s IUD clinical trial data
to explore the incidence and patterns of the pelvic in-
flammatory disease (PID) risk with use of an IUD [9].
The overall rate of PID among 22.908 IUD insertions of
a combined 51.399 woman years were about 1.6 cases
per 1000 woman years of use. After adjustments of con-
founding factors, PID (pelvic inflammatory disease) risk
was more than six times higher during the 20 days after
insertion than during later times (unadjusted rates, 9.7
versus 1.4 per 1000 woman years, respectively) the risk
was low and constant for up to eight years following up.
Rates varied according to geographical area (highest in
Africa and lowest in China) and were inversely associ-
ated with age. PID rates were lower among women who
had IUDs inserted more recently [9].
In our case, the patient had no complains about the
intrauterine device. She had never experienced bleeding
episodes after a menopause and a pathohistological exam
was clear of abnormal cells or infectious components in
the curettage material.
Nowadays, intrauterine devices are one of the most
frequently used reversible family planning methods in
the world. The earlier IUD that was made of plastic
materials has been replaced by new devices releasing
copper or levonorgestrel. These modifications increased
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study was done in the US to analyze satisfaction and
continuation of using different contraceptive methods.
12-month data from 5078 participants was analyzed.
Continuation rates for long-acting reversible contracep-
tive methods ranged from 83 to 88% (women who were
using IUD or the implant). The rates for other contra-
ception forms (contraceptive pills and rings) ranged
from 54 to 57%. It was concluded that long-acting revers-
ible contraceptive methods are most effective and not
user-dependent [2]. Many experts believe that IUD has
highest continuation rates and the highest level of satisfac-
tion amongst all the methods of contraception [2,3,5].
Conclusions
Fifty years of prolonged usage of LIPPES IUD had no in-
fluence on women’s health in our case. For fifty years
the patient was healthy, did not contract any diseases,
PID or required surgery. IUD was found occasionally
(the patient forgot about it) when the patient got admit-
ted due to stress urinary incontinence.
Consent
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